oxidopamine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jiménez-Urbieta, H | 1 |
Gago, B | 1 |
Quiroga-Varela, A | 1 |
Rodríguez-Chinchilla, T | 1 |
Merino-Galán, L | 1 |
Delgado-Alvarado, M | 1 |
Navalpotro-Gómez, I | 1 |
Belloso-Iguerategui, A | 1 |
Marin, C | 1 |
Rodríguez-Oroz, MC | 1 |
Rokosik, SL | 1 |
Napier, TC | 1 |
Winstanley, CA | 1 |
Theobald, DE | 1 |
Dalley, JW | 1 |
Robbins, TW | 1 |
3 other studies available for oxidopamine and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.
Topics: Animals; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Ago | 2020 |
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benzothiazoles; Biophysics; | 2012 |
Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Amphetamine; Ani | 2005 |